Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,144
datasets available to search
ShareScore release 0.9.0
Dataset results
6,144 results for “cancer treatment”
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
ClinicalTrials.gov study NCT02973789. IPD Sharing: UNDECIDED. Countries: 18. Publications: 10.
Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)
ClinicalTrials.gov study NCT00945139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
ClinicalTrials.gov study NCT04035486. IPD Sharing: YES. Countries: 21. Publications: 7.
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-
ClinicalTrials.gov study NCT03517449. IPD Sharing: Not stated. Countries: 21. Publications: 5.
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
ClinicalTrials.gov study NCT02868242. IPD Sharing: YES. Countries: 1. Publications: 1.
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
ClinicalTrials.gov study NCT02759835. IPD Sharing: YES. Countries: 1. Publications: 2.
Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT01843062. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherap
ClinicalTrials.gov study NCT01079780. IPD Sharing: YES. Countries: 1. Publications: 1.
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02681549. IPD Sharing: NO. Countries: 1. Publications: 1.
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
ClinicalTrials.gov study NCT02803203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT03778931. IPD Sharing: YES. Countries: 17. Publications: 3.
Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.
ClinicalTrials.gov study NCT01750281. IPD Sharing: YES. Countries: 8. Publications: 1.
Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer
ClinicalTrials.gov study NCT00715104. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
ClinicalTrials.gov study NCT00121992. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT00668811. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
ClinicalTrials.gov study NCT00796445. IPD Sharing: YES. Countries: 32. Publications: 2.
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00630552. IPD Sharing: Not stated. Countries: 1. Publications: 3.
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
ClinicalTrials.gov study NCT00382018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00308750. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High
ClinicalTrials.gov study NCT04523207. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.